Clinical Trial

PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma

Study acronym: RAPID
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
RATIONALE: A PET scan may help doctors learn how the cancer responded to combination chemotherapy and whether radiation therapy is also required. PURPOSE: This randomized phase III trial is studying giving a PET scan to see how well it works in deciding whether patients who have received combination chemotherapy for stage IA or stage IIA Hodgkin lymphoma also need radiation therapy.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2009-07-21; most recent amendment 2023-11-29.
Status change: Recruiting → Active, Not Recruiting 2013-05-09
Trial Details
NCT Number NCT00943423
Lead Sponsor University College, London
Collaborators: The Christie NHS Foundation Trust
Conditions Lymphoma
Enrollment 602 participants
Start Date 2003-07
Primary Completion 2014-07 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2023-11-30